Stock COPN COSMO PHARMACEUTICALS N.V.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Cosmo Pharmaceuticals N.V.

Equities

COPN

NL0011832936

Market Closed - Swiss Exchange
Other stock markets
 11:30:12 2024-05-24 am EDT 		5-day change 1st Jan Change
71.5 CHF -1.65% Intraday chart for Cosmo Pharmaceuticals N.V. -1.92% +40.47%
Apr. 26 Cosmo Pharmaceuticals N.V. Announces Executive Changes at the Upcoming Annual General Meeting on 24 May 2024 CI
Apr. 25 Cosmo Pharmaceuticals Names New CEO, Chairman MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Berenberg Lifts Price Target on Cosmo Pharmaceuticals, Maintains Buy Recommendation
MT
Berenberg EU Opportunities Conference
FA
Cosmo Pharmaceuticals Partner Medtronic Says GI Genius Endoscopy Lowers Colorectal Polyps Miss Rate
MT
Cosmo Pharmaceuticals' GI Genius Device Cuts Adenoma, Polyp Miss Rate in Colonoscopy
MT
Cosmo Pharmaceuticals N.V. Detects Study Shows AI Assistance Using GI Genius? Reduces Missed Polyp Rate by Nearly 50% on Initial Colonoscopy
CI
COSMO PHARMACEUTICALS N : Research Partners Lowers Price Target on Cosmo Pharmaceuticals, Maintains Buy Recommendation
MT
COSMO PHARMACEUTICALS N : Research Partners Lifts Price Target on Cosmo Pharmaceutical, Maintains Buy Recommendation
MT
Berenberg European Conference
FA
Berenberg USA Conference
FA
Berenberg European Conference
FA
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. COPN Stock
  4. News Cosmo Pharmaceuticals N.V.
  5. Analyst Reco.